Hospitalisations pour neutropénie fébrile chimio-induite en France en 2010–2011 : impact clinique et caractéristiques des patients à partir des données de la base PMSI
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Reference19 articles.
1. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients;Kuderer;Cancer,2006
2. Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice;Crawford;J Natl Compr Canc Netw,2008
3. Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study;Pettengell;Support Care Cancer,2008
4. Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study;Culakova;Cancer Med,2014
5. Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer;Stokes;J Manag Care Pharm,2009
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Use of Granulocyte Colony-Stimulating Factor as Primary Prophylaxis in Patients Undergoing Chemotherapy: An Experience of Moroccan Oncologists;Cureus;2024-02-19
2. [18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial;The Lancet Haematology;2022-08
3. Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data;Journal of Medical Economics;2021-01-01
4. Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor;Journal of Infection;2019-08
5. Prospective study of a web-mediated management of febrile neutropenia related to chemotherapy (Bioconnect);Supportive Care in Cancer;2018-10-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3